HomeMarkets overviewSharesVor Biopharma Inc.

Trade Vor Biopharma Inc. - VOR CFD

Market is not available at the momentMarket information is presented
as of 2026-07-31T19:45:37+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.17
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.021568 %
(-$4.31)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $19,000.00


-0.02157%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000654 %
(-$0.13)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $19,000.00


-0.00065%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity10
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close21.7
Open21.35
1-Year Change866.06%
Day's Range20.41 - 21.35

Trade Vor Biopharma Inc. - VOR

What is Vor Biopharma Inc. (VOR)?

Vor Biopharma Inc. is a biotechnology company engaged in the development of cellular therapies for hematologic malignancies. The company focuses on engineered hematopoietic stem cells designed to target and eliminate cancerous blood cells while preserving healthy cells. Its research and development efforts include gene editing and immunotherapy techniques aimed at improving treatment outcomes for blood cancers. Vor Biopharma operates in the biopharmaceutical sector, collaborating with academic institutions and leveraging advanced scientific methodologies. The company’s approach involves modifying stem cells to enhance their therapeutic potential and reduce adverse effects. It is subject to regulatory oversight related to clinical trials, manufacturing, and product approval processes. Vor Biopharma’s activities contribute to the broader field of precision medicine and cellular therapy innovation.

Vor Biopharma Inc. Stock Price Today: Live Overview

The price today is shaped by current market trading, with Vor Biopharma Inc. priced at $20.93. Its price has fluctuated between $20.38 and $21.4, reflecting a daily change of -4.1781%.

FAQ: Vor Biopharma Inc. (VOR)

What is the current price of VOR stock?

The stock is currently priced at $20.93.

Does VOR pay dividends?

Vor Biopharma Inc. does not pay dividends.

Does VOR have a formal corporate presence or regional headquarters in the UAE?

Vor Biopharma Inc. does not have a registered presence or office in the UAE and operates internationally without a local subsidiary.

What is VOR best known for?

The company is most famous for its development of targeted therapies for hematologic malignancies.

What assets are typically shown together with VOR?

Commonly shown alongside VOR: Yamato Holdings Co., Ltd., Basler AG, Zoom Video Communications Inc

Latest shares articles

Michael Kramer: How to Analyse AMD Before Earnings
Michael Kramer: How to Analyse AMD Before Earnings
AMD’s market capitalisation has risen since late 2022, climbing from roughly $90 billion to a 2026 peak of just below $950 billion before falling to $851 billion as of 24 July 2026.
4 hours ago
SanDisk logo displayed on the exterior of a company office building, representing the flash memory and data storage technology manufacturer.
Michael Kramer: How to Analyse SanDisk Before Earnings
SanDisk’s market capitalisation rose from roughly $5.6 billion at its February 2025 listing, after touching a low of about $4 billion in April 2025, to a 2026 high of approximately $346 billion, before settling at $213 billion on 24 July 2026.
4 hours ago
Intel stock forecast: What’s next for INTC after poor earnings? Close up of Intel sign at entrance of The Intel Museum in Silicon Valley.
Intel stock forecast: What’s next for INTC after poor earnings?
Intel shares rose after the company reported second-quarter 2026 revenue of $16.13bn, adjusted earnings of $0.42 per share and new foundry engagements. Explore third-party INTC price targets and technical analysis.
12:21, 31 July 2026
IonQ, Inc. Stock Forecast
IonQ stock forecast: Third-party price targets
IonQ develops trapped-ion quantum systems and reported a $96.80m adjusted EBITDA loss in the first quarter of 2026 as it worked towards a 256-qubit system. Explore third-party IONQ price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:41, 30 July 2026
Related News
Public TechnologiesEurope
20:55 (UTC), 21 July 2026
RA Capital Healthcare Fund disposes of 213 Vor Biopharma shares worth $4,206.75

User feedback and ratings

2025-07-01
Victor Flemming Nandwa Søder

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-07-01
Perry Reineke

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-06-29
proinpro

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

2025-06-27
Gio Gvazava

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-27
Douglas

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-22
Jean A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-19
foobarbeer

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-06-19
Casaubon70

Love the TV integration. Makes traders life smooth and comfortable.

2025-06-19
dgogidze7

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-05-30
Brigman

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-05-24
Radioilluminati

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-05-20
GemzT

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
dmjnoor

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-03-24
Debbie P

The best trading company I've found so far and so easy to use.

2025-02-06
Nouman Butt

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

Showing our 4 & 5 star reviews.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready